蛋白體學：各種技術及全球市場 是由出版商BCC Research在2009年06月所出版的。
這份英文市場調查報告書包含226 pages 價格從美金4850起跳。
本報告書內容包括：全球蛋白體學市場動向之地區・技術類型・產品/服務・應用等各種分類別調查分析、市場規模現況・ 預測（至2014年）、市場成長刺激因素・阻礙因素、主要企業、最近的發展動向等。內容綱要摘記如下：
第1章 摘要
第2章 市場概要
第3章 全球蛋白體學機器市場
- 蛋白質晶片・微陣列
- 生物晶片/載片
- 微陣列
- 掃描器
- 整合系統
- 蛋白質解析系統/蛋白體學系統
- 蛋白質・蛋白質相互作用/親和性特性化系統
- 膜蛋白質解析系統
- 蛋白質相互作用監視系統：試藥
- 蛋白質的分畫系統
- SPR系統
- 2-DE市場
- 2-DGE系統
- 等電點電泳系統
- MF晶片技術/MF系統
- 利用MF晶片及晶片的免疫分析法
- 離子源
- MALDI
- ESI
- 質量分析器
- 試藥及抗體
- 高效能離子層析系統
- LC/MS系統
- HPLC系統
- 離子高效能離子層析系統
- 奈米級HPLC系統
- GC/MS系統
- 膠體滲透層析高效能離子層析系統、等
第4章 蛋白體學技術市場
第5章 蛋白體學服務市場
- 分析實驗室服務
- 蛋白質品質控制・蛋白質鑑定
- 蛋白質分離服務
- 蛋白質定序服務
- 資料解析・維持
第6章 蛋白體學資料庫・軟體市場
- 蛋白體學軟體
- MS軟體
- 微陣列軟體
- 蛋白質結構解析
- 串聯型質量分析計蛋白體學資料瀏覽器
- 蛋白質・縮氨酸鑑定軟體
- 蛋白體學資料庫
- 蛋白質・蛋白質的相互作用
- 蛋白質排列資料庫
- 蛋白質及基因、等
第7章 蛋白體學應用市場
- 藥物發現
- 藥物開發
- 藥物標的檢驗
- 診斷市場
- 新的生物標記
- 蛋白質・蛋白質的相互作用
- 蛋白質精製
- 蛋白質鑑定
- 食品・營養
- 國土安全保障、等
第8章 地區分析
第9章 企業介紹
第10章 附錄
Abstract
REPORT HIGHLIGHTS
The global market for proteomics is expected to increase from $6.7 billion in
2008 to an estimated $7.9 billion in 2009 and $19.4 billion in 2014, for a
compound annual growth rate (CAGR) of 19.7%. Proteomics equipment was valued
at $4.1 billion in 2008 and an estimated $4.8 billion in 2009. This is
expected to increase to $13.0 billion in 2014, for a CAGR of 22%.. Proteomics
technologies were worth $1.3 billion in 2008 and an estimated $1.5 billion in
2009. This segment is expected to increase at a CAGR of 13.9% to reach $2.9
billion in 2014.
STUDY GOALS AND OBJECTIVES
- To define global proteomics market and other aligned markets,
technologies, and terms.
- To measure the global proteomics market with respect to technologies,
equipment, services, database, and software and applications.
- To analyze intensively the market structure with respect to drivers,
inhibitors, and challenges influencing the market growth.
- To identify the trends, gaps, and opportunities in each of the
micro-markets.
- To analyze and forecast the revenues of market segments with respect to
geographies (North America, Europe, Asia, and the rest of the world or ROW).
- To strategically profile and analyze the market players and their core
competencies in the field of proteomics for each of its market segment.
- In-depth analysis of competitive scenario, top-selling products, and
services of the proteomics market.
- To track and analyze recent developments, alliances, joint ventures,
mergers, and acquisitions of the market players in the industry.
REASONS FOR DOING THE STUDY
The transformation of the biopharmaceutical industry' s focus from genomics to
system biology has enormously increased the importance of proteomics. The need
to develop more reliable and cost-effective drugs and increasing emphasis on
personalized medicines are necessitating in-depth research on proteomics. The
growing awareness of protein study and research has opened up the market for
various proteomic-related technologies, equipment, and services.
However, the lack of comprehensive research pertaining to this segment has
always been a restraint for stakeholders. Existing reports do not provide
detailed information pertaining to equipment market, complete services, a
proteomic database, and software markets. This report covers the above
information extensively, and includes segmentation by applications. This
report not only focuses on the subsegments discussed, it also provides a
complete picture of the micro-market under every subsegment portraying a
complete and realistic scenario of the proteomic industry.
SCOPE OF REPORT
The report discusses segmentation of the global proteomics market as follows:
- Technologies (based on kinds of proteomics, process and component and
applications)
- Database and software market (proteomics database, software, laboratory
software programs)
- Equipment market (2-D electrophoresis or 2-DE, chromatography systems,
mass spectrometry, microfluidic (MF) chip technology and systems, microsphere
analysis components, proteomics systems, protein microarrays, and others).
- Applications market (scientific and clinical applications, and others,
including homeland security and personalized medicines)
- Services market (laboratory services, database analysis and maintenance,
and others)
Each of the sections will provide market data, market drivers, trends and
opportunities, top-selling products, key players, and a competitive outlook.
This report will also provide more than 100 market tables for various
geographic regions covering the subsegments and micro-markets. In addition,
the report also provides 50 company profiles across subsegments, such as
protein chip providers, reagent providers, service providers, informatics and
database providers, and so on.
INTENDED AUDIENCE
The intended audience includes the following:
- Proteomics technology providers
- Proteomics equipment manufacturers and dealers
- Proteomics laboratory service providers
- Proteomics database and software providers
- Biopharmaceutical (drug design and discovery) companies
- Proteomics research companies and institutes
- Proteomics associations
INFORMATION SOURCES
All the market data will consist of aggregate sales figures of all submarkets
within proteomics. The report focuses on the market aspects of the proteomics
industry rather than on the technical aspects. We analyzed most of the new
technology and product launches in the proteomics market and studied more than
500 news items. Key market developments will be sourced from the top 50
companies profiled. We researched all the technology patents over the last 5
years and documented proteomics claims to get an in-depth understanding of the
utility of equipment and technology. Primary and secondary research progressed
through both paid and unpaid sources to provide a greater understanding of the
proteomics industry.
Table of Contents
Chapter-1: SUMMARY 2
- SUMMARY TABLE GLOBAL PROTEOMICS MARKET BY EQUIPMENT, DATABASE AND
SOFTWARE, TECHNOLOGY, AND SERVICES, THROUGH 2014 ($ MILLIONS) 5
- SUMMARY FIGURE GLOBAL PROTEOMICS MARKET BY EQUIPMENT, DATABASE AND
SOFTWARE, TECHNOLOGY, AND SERVICES, 2007-2014 ($ MILLIONS) 6
Chapter-2: MARKET OVERVIEW 21
- FIGURE 1 EVOLUTION OF PROTEOMICS AND FUTURE TRANSITION 7
- DEFINING THE PROTEOMICS MARKET 8
- FIGURE 2 PROTEOMICS MARKET DEFINITION CHART 9
- TECHNOLOGICAL INNOVATION BOOSTING PROTEOMICS EQUIPMENT MARKET 10
- FIGURE 3 RELATIVE IMPORTANCE OF PROTEOMICS SYSTEMS AND TECHNOLOGY ISSUES 10
- FIGURE 4 BCG MATRIX FOR PROTEOMICS EQUIPMENT MARKET, 2009 11
- TECHNOLOGY REMAINS THE KEY ENABLER 12
- FIGURE 5 PATENT ANALYSIS BY TECHNOLOGY, 2006 (%) 13
- FIGURE 6 PATENT ANALYSIS BY TECHNOLOGY, 2008 (%) 14
- EMERGENCE OF PROTEOMICS SERVICES MARKET 15
- FIGURE 7 BCG MATRIX FOR PROTEOMICS SERVICE MARKET - ANALYTICAL LABORATORY
SERVICES, 2009 15
- KEY FACTORS INFLUENCING THE PROTEOMICS MARKET 16
- FIGURE 8 KEY MARKET FACTORS INFLUENCING THE GROWTH OF PROTEOMICS 17
- PROTEOMICS MARKET LED BY U.S. CENTRIC PLAYERS 17
- FIGURE 9 PATENT ANALYSIS BY ASSIGNEE, 2009* (%) 18
- INCREASING ADOPTION OF PROTEOMICS IN DRUG DISCOVERY 19
- FIGURE 10 CURRENT AND FUTURE POTENTIAL FOR PROTEOMICS APPLICATION MARKET 20
- EQUIPMENT PROVIDERS ARE KEY EARNERS AND DRUG DISCOVERY COMPANIES ARE KEY
INVESTORS 20
- FIGURE 11 SUPPLY SIDE STAKEHOLDER ANALYSIS, 2009 (%) 21
- FIGURE 12 DEMAND SIDE STAKEHOLDER ANALYSIS, 2009 (%) 22
- MARKET DRIVERS 22
- DRAWBACKS OF GENOMICS IGNITING THE GROWTH OF PROTEOMICS: 22
- NEED TO IMPROVE THE SPEED AND EFFICIENCY OF DRUG DISCOVERY 23
- PROTEOMICS LEADS TO INCREASE IN R&D PRODUCTIVITY 23
- CONTINUED DEVELOPMENT OF TECHNOLOGIES 23
- CAPABILITY OF PROTEOMICS IN DEVELOPING PERSONALIZED THERAPY 24
- LOWER SAMPLE REQUIREMENTS LEADS TO COST EFFECTIVENESS 24
- IDENTIFICATION OF 3-D STRUCTURE OF PROTEINS AIDS IN DRUG DESIGN 24
- MULTI-TASKING PLATFORMS CONFIRM THE ROLE OF TARGET PROTEINS IN DISEASE 24
- MARKET INHIBITORS 25
- MASSIVE DIVERSIFIED DATA LEADS TO THE NEED OF STRUCTURING A STANDARD FORM
25
- STRUCTURING OF PROTEINS REQUIRES EXPENSIVE TOOLS AND MACHINES LEADING TO
LOWER ADOPTION RATES 25
- NEED FOR WELL-QUALIFIED RESEARCHERS AND MANDATORY TRAINING, INCREASES THE
COST FACTOR 25
- COST AND REIMBURSEMENT COMPLEXITIES EMERGING AS MAJOR HINDRANCES 26
- NEED FOR MORE SOPHISTICATED TOOLS FOR HIGHER-END ANALYSIS 26
- RIGID STRUCTURE OF PROTEINS COMPLICATE FURTHER RESEARCH 26
- LACK OF TECHNOLOGIES TO SPEED UP VALIDATION PROCESS 26
- OPPORTUNITIES 27
- BIO MARKER IDENTIFICATION OPENING OPPORTUNITIES 27
- COMBINATION OF PROTEOMICS AND METAOLOME STUDIES COULD LEAD TO EFFECTIVE
PERSONALIZED MEDICINES 27
- THE INTEREST OF PROTEOMICS PRODUCTS AND SERVICE SUPPLIERS ENSURES GROWTH
OF PROTEOMICS 27
- PROTEOMICS DATA ANALYSIS LEADS TO MORE AND IMPROVED DRUGS 27
Chapter-3: GLOBAL PROTEOMICS EQUIPMENT MARKET 60
- TABLE 1 GLOBAL PROTEOMICS EQUIPMENT MARKET BY PRODUCT, THROUGH 2014 ($
MILLIONS) 28
- TABLE 2 GLOBAL PROTEOMICS EQUIPMENT MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ MILLIONS) 29
- PROTEIN CHIPS AND MICROARRAYS 29
- TABLE 3 GLOBAL PROTEIN CHIPS AND MICROARRAYS MARKET BY PRODUCT, THROUGH
2014 ($ MILLIONS) 30
- TABLE 4 GLOBAL PROTEIN CHIPS AND MICROARRAYS MARKET, THROUGH 2014 ($
MILLIONS) 30
- TOP PLAYERS 30
- TABLE 5 RECENT DEVELOPMENTS 31
- BIOCHIPS/SLIDES 31
- TABLE 6 GLOBAL BIO CHIPS/SLIDES MARKET BY GEOGRAPHIC REGION, THROUGH 2014
($ MILLIONS) 32
- Market Drivers 32
- Measurement Done by Protein Biochips is Much Easier than Other Traditional
Methods of Research 32
- Protein Biochips Take Less Time for Analysis, which Makes Them Favorites
for Protein Expression Profiling 32
- Presence of Competitive Methods for Protein Identification Acts as an
Obstacle for Protein Biochips 33
- MICROARRAYS 33
- TABLE 7 GLOBAL MICROARRAYS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 33
- TABLE 8 GLOBAL MICROARRAYS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
MILLIONS) 34
- Market Drivers 34
- Multi Processing Capacity of Microarrays Driving its Adoption Rate in
Proteomics 34
- Microarrays Provide Complete Protein Profiling Leading to its Utilization
in Basic Research 34
- Minimal Use of Materials Makes Microarrays an Inexpensive Technology 35
- Use of Recombinant Methods Establishes Direct Connectivity between DNA
Sequences 35
- Growth of Pharmaceutical Industry is Leading to the Growth of the
Microarray Market 35
- SCANNERS 35
- TABLE 9 GLOBAL SCANNERS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 36
- INTEGRATED SYSTEMS 36
- TABLE 10 GLOBAL INTEGRATED SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ THOUSANDS) 36
- PROTEIN ANALYSIS SYSTEM/PROTEOMICS SYSTEM 37
- TABLE 11 GLOBAL PROTEIN ANALYSIS SYSTEM/PROTEOMICS SYSTEM MARKET BY
PRODUCT, THROUGH 2014 ($ MILLIONS) 37
- TABLE 12 GLOBAL PROTEIN ANALYSIS SYSTEM/PROTEOMICS SYSTEM MARKET BY
GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 38
- PROTEIN-PROTEIN INTERACTION/AFFINITY CHARACTERIZATION SYSTEMS 38
- TABLE 13 GLOBAL PROTEIN-PROTEIN INTERACTION/AFFINITY CHARACTERIZATION
MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 38
- MEMBRANE PROTEIN ANALYSIS SYSTEMS 39
- TABLE 14 GLOBAL MEMBRANE PROTEIN ANALYSIS SYSTEMS MARKET BY GEOGRAPHIC
REGION, THROUGH 2014 ($ MILLIONS) 39
- PROTEIN INTERCATION MONITORING SYSTEMS - REAGENTS 39
- TABLE 15 GLOBAL PROTEIN INTERACTION MONITORING SYSTEMS REAGENTS MARKET BY
GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 40
- PROTEIN FRACTIONATION SYSTEMS 40
- TABLE 16 GLOBAL PROTEIN FRACTIONATION SYSTEM MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ MILLIONS) 40
- SPR SYSTEMS 41
- TABLE 17 GLOBAL SPR SYSTEM MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 41
- 2-DE MARKET 42
- TABLE 18 GLOBAL 2-DE MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 42
- TABLE 19 GLOBAL 2-DE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
MILLIONS) 43
- MARKET DRIVERS 43
- Enhanced Features of This System Lead to Higher Throughput 43
- Collection of Substantial Amount of Information through Image Analysis and
Data Mining Solutions 43
- Investments by Researchers Leading To the Growth of This System 44
- This System Consumes Time and is Labor Intensive 44
- RECENT DEVELOPMENTS 44
- 2-DGE SYSTEMS 44
- TABLE 20 GLOBAL 2-DGE SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
MILLIONS) 44
- Market Drivers 45
- Growth of 2-DGE Market Ignites the Growth for 2-DGE Systems 45
- Use of 2-DGE in Medical Applications Escalating Demand for Proteomics
Systems: 45
- 2-DE Systems Complement Other Techniques, Which Adds to Their Application
Portfolio: 45
- Difficulties Associated with 2-D Gels Restrict 2-DE Systems from Being
Used at Full Potential 45
- ISOELECTRIC FOCUSING SYSTEMS (FRACTIONATORS, GELS, AND STRIPS) 46
- TABLE 21 GLOBAL ISOELECTRIC FOCUSING SYSTEMS (FRACTIONATORS, GELS, AND
STRIPS) MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 46
- Market Drivers 46
- Multi-Metric Composition Leading to High Resolution and Purity of Samples
46
- Negligible Interactions with Metal Ions 47
- User Friendly 47
- Others Factors Driving the Market 47
- 2-DE CELLS 47
- TABLE 22 GLOBAL 2-DE CELLS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 47
- 2-D PROTEIN MW MARKERS 48
- TABLE 23 GLOBAL 2-D PROTEIN MW MARKERS MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 48
- MF CHIP TECHNOLOGY/MF SYSTEMS 48
- TABLE 24 GLOBAL MF CHIP TECHNOLOGY/MF SYSTEM MARKET BY PRODUCT, THROUGH
2014 ($ MILLIONS) 49
- TABLE 25 GLOBAL MF CHIP TECHNOLOGY/MF SYSTEM MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ MILLIONS) 49
- MARKET DRIVERS 49
- A Tool for Analyzing the Drug' s Effectiveness, Pharmacological Profiling,
and Toxicity Testing 50
- Significant Contribution to the Field of Diagnosis and Treatment 50
- Helpful In the Detection of Various Non-Communicable Diseases 50
- A Significant Role in the Field of Quality Control 50
- Minimum Wastage, Low Reagents Costs, and Less Requirement of the Sample
Volume for Diagnostics 50
- Others 51
- MARKET INHIBITORS 51
- LOC is a Novel Technology that Requires Further Refinement 51
- Precision Engineering Still Remain Comparatively Sophisticated 51
- TOP PLAYERS 52
- TABLE 26 RECENT DEVELOPMENTS 52
- MF CHIPS AND CHIPS-BASED IMMUNOASSAYS 52
- TABLE 27 GLOBAL MF CHIPS AND CHIP-BASED IMMUNOASSAYS MARKET BY GEOGRAPHIC
REGION, THROUGH 2014 ($ MILLIONS) 53
- MARKET DRIVERS 53
- Cost-Effective Complex Analysis System Can Be Developed on a MF Chip 53
- MF Chip Acts as an Essential Tool for MS 53
- Complete Automation in a Single Device Leads to Reduction in Accidental
Loss of Reagents 54
- Microchips Enable Greater Speed and Higher Quality of Output 54
- The Minimal Requirement of Samples Results in Cost Reduction 54
- MF Chip Technology Unable to Mix Fluids on the Chips in an Effective
Manner, Making Them Less Favorable for Analysis of Complex Fluids 54
- HTS 54
- TABLE 28 GLOBAL HTS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 55
- MARKET DRIVERS 55
- A Tool for Speedy Accomplishment of Biochemical, Genetic, or
Pharmacological Tests 55
- Demand in Academia 56
- The Combination of HTS and uHTS Has a Lot of Advantages 56
- HTS Increases Cost-Effectiveness and Productivity 56
- Others 56
- MICROSPHERE ANALYSIS 57
- TABLE 29 GLOBAL MICROSPHERE ANALYSIS MARKET BY PRODUCT, THROUGH 2014 ($
MILLIONS) 57
- TABLE 30 GLOBAL MICROSPHERE ANALYSIS MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ MILLIONS) 57
- ASSAY REAGENTS (MICROSPHERE) 58
- TABLE 31 GLOBAL FLUORESCENT MICROSPHERE ASSAY AND REAGENT MARKET BY
GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 58
- MULTIPLEX ASSAY SYSTEM/FLUORESCENCE MULTIPLEX ARRAYS 58
- TABLE 32 GLOBAL MULTIPLEX ASSAY SYSTEMS/FLUORESCENCE MULTIPLEX ARRAYS
MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 59
- MICROSPHERES AND ASSAY KITS 59
- TABLE 33 GLOBAL MICROSPHERES AND ASSAY KITS MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 60
- MS 60
- TABLE 34 GLOBAL MS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 60
- TABLE 35 GLOBAL MS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
61
- MARKET DRIVERS 61
- Simple Quantification of Protein Structures Generates the Need for MS 61
- MS Acts as a Supporting Element for Growing Technologies 61
- Gaining Popularity of Hybrid MS Instruments is Boosting the Growth for MS
61
- MARKET INHIBITORS 62
- MS Fails to Analyze Small Quantities of Proteins 62
- Manual Interruption Necessary, Increasing the Error Rate 62
- TOP PLAYERS 62
- TABLE 36 RECENT DEVELOPMENTS 62
- TABLE 36 (CONTINUED) 63
- IONIZATION SOURCES 63
- TABLE 37 GLOBAL IONIZATION SOURCES MARKET BY PRODUCT, THROUGH 2014 ($
MILLIONS) 64
- TABLE 38 GLOBAL IONIZATION SOURCES MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ MILLIONS) 64
- MALDI 64
- TABLE 39 GLOBAL MALDI MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 65
- ESI 65
- TABLE 40 GLOBAL ESI MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 65
- Atmospheric Pressure Chemical Ionization (APCI) 66
- TABLE 41 GLOBAL APCI MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 66
- MASS ANALYZERS 66
- TABLE 42 GLOBAL MASS ANALYZERS MARKET BY GEOGRAPHIC REGION, THROUGH 2014
($ THOUSANDS) 67
- OTHERS 67
- TABLE 43 GLOBAL OTHER EQUIPMENT MARKET BY PRODUCT, THROUGH 2014 ($
MILLIONS) 67
- TABLE 44 GLOBAL OTHER EQUIPMENT MARKET BY GEOGRAPHIC REGION, THROUGH 2014
($ MILLIONS) 68
- REAGENTS AND ANTIBODIES 68
- TABLE 45 GLOBAL REAGENT AND ANTIBODIES MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ MILLIONS) 68
- AUTOMATED LIQUID HANDLING WORKSTATIONS 69
- TABLE 46 GLOBAL AUTOMATED LIQUID HANDLING WORKSTATIONS MARKET BY
GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 69
- SPOT PICKERS 69
- TABLE 47 GLOBAL SPOT PICKERS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 70
- TOP PLAYERS 70
- RECENT DEVELOPMENTS 70
- Agreements and Collaborations (December 8, 2008) 70
- CHROMATOGRAPHY SYSTEMS 71
- TABLE 48 GLOBAL CHROMATOGRAPHY SYSTEMS MARKET BY PRODUCT, THROUGH 2014 ($
MILLIONS) 71
- TABLE 49 GLOBAL CHROMATOGRAPHY SYSTEMS MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ MILLIONS) 72
- MARKET DRIVERS 72
- LC/MS SYSTEMS 73
- TABLE 50 GLOBAL LC/MS SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 73
- TOP PLAYERS 74
- TABLE 51 RECENT DEVELOPMENTS 74
- HPLC SYSTEMS 74
- TABLE 52 GLOBAL HPLC SYSTEMS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS)
75
- TABLE 53 GLOBAL HPLC SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 75
- ION CHROMATOGRAPHY SYSTEMS 76
- Market Drivers 76
- Reduces the Analysis Time Leading to Higher Efficiency 76
- Higher Sensitivity Ensuring Higher Accuracy Levels 76
- Simultaneous Detection of Numerous Samples 76
- TABLE 54 GLOBAL ION CHROMATOGRAPHY SYSTEMS MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 76
- NANOSCALE HPLC SYSTEMS 77
- TABLE 55 GLOBAL NANOSCALE HPLC SYSTEMS MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 77
- GC/MS SYSTEMS 77
- TABLE 56 GLOBAL GC/MS SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 78
- TOP PLAYERS 78
- TABLE 57 NEW PRODUCT DEVELOPMENT 79
- COMPLETE PROTEIN PURIFICATION SYSTEMS 79
- Market Drivers 79
- User Friendly 79
- Speedy and Suitable Start to All Purification 79
- TABLE 58 GLOBAL COMPLETE PROTEIN PURIFICATION SYSTEMS MARKET BY GEOGRAPHIC
REGION, THROUGH 2014 ($ THOUSANDS) 80
- GEL PERMEATION CHROMATOGRPAHY SYSTEMS 80
- TABLE 59 GLOBAL GEL PERMEATION CHROMATOGRAPHY SYSTEMS MARKET BY GEOGRAPHIC
REGION, THROUGH 2014 ($ THOUSANDS) 81
- COMPLETE LC-NMR-MSN SYSTEMS 81
- TABLE 60 GLOBAL COMPLETE LC-NMR-MSN SYSTEMS MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 81
- Market Drivers 82
- CHROMATOGRAPHY SYSTEM ACCESSORIES 82
- Market Drivers 82
- TABLE 61 GLOBAL CHROMATOGRAPHY SYSTEM ACCESSORIES MARKET BY GEOGRAPHIC
REGION, THROUGH 2014 ($ THOUSANDS) 83
- SUPERCRITICAL FLUID CHROMATOGRAPHY AND EXTRACTION SYSTEMS 83
- TABLE 62 GLOBAL SUPERCRITICAL FLUID CHROMATOGRAPHY AND EXTRACTION MARKET
BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 84
- CAPILLARY LC SYSTEMS 84
- TABLE 63 GLOBAL CAPILLARY LC SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ THOUSANDS) 85
- AUTOMATED SPE SYSTEMS 85
- TABLE 64 GLOBAL AUTOMATED SPE SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ THOUSANDS) 86
- Market Growth 86
- These Systems Are Good Platforms for Direct Injections of Plasma, Urine,
Vegetable Oils, and Surface Water 86
- These Systems Automate Cleaning of Sample and Analyte Enrichment 86
- These Systems Eliminate Traditional Manual Sample Steps, Making Them
Inexpensive Platforms for Speedy Analysis 86
- Other Driving Factors 87
- Need for Human Intervention Absorbs Enormous Time 87
Chapter-4: PROTEOMICS TECHNOLOGY MARKET 18
- TABLE 65 GLOBAL PROTEOMICS TECHNOLOGY MARKET BY PRODUCT, THROUGH 2014 ($
MILLIONS) 88
- TABLE 66 GLOBAL PROTEOMICS TECHNOLOGY MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ MILLIONS) 88
- BASED ON TYPES 89
- TABLE 67 GLOBAL PROTEOMICS TECHNOLOGY MARKET BASED ON PRODUCT TYPES,
THROUGH 2014 ($ MILLIONS) 89
- TABLE 68 GLOBAL PROTEOMICS TECHNOLOGY MARKET BASED ON TYPES BY GEOGRAPHIC
REGION, THROUGH 2014 ($ MILLIONS) 89
- STRUCTURAL PROTEOMICS 89
- TABLE 69 GLOBAL STRUCTURAL PROTEOMICS MARKET BY PRODUCT, THROUGH 2014 ($
MILLIONS) 90
- TABLE 70 GLOBAL STRUCTURAL PROTEOMICS MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ MILLIONS) 90
- X-Ray Crystallography 90
- TABLE 71 GLOBAL X-RAY CRYSTALLOGRAPHY MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ MILLIONS) 91
- Market Drivers 92
- Application in Drug Discovery Boosting Market Growth 92
- Simple and Low Cost Solution Increasing Adoption Rates 92
- Aids Effective Analysis in Short Span of Time 92
- Top Players 92
- TABLE 72 ACQUISITIONS/MERGERS/JOINT VENTURES 93
- Recent Developments 93
- March 27, 2008 Agreements and Collaborations 93
- NMR Spectroscopy 93
- TABLE 73 GLOBAL NMR SPECTROSCOPY MARKET BY GEOGRAPHIC REGION, THROUGH 2014
($ MILLIONS) 94
- EXPRESSIONAL PROTEOMICS 95
- TABLE 74 GLOBAL EXPRESSIONAL PROTEOMICS MARKET BY PRODUCT, THROUGH 2014 ($
MILLIONS) 95
- TABLE 75 GLOBAL EXPRESSIONAL PROTEOMICS MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ MILLIONS) 95
- Serial Analysis of Gene Expression (SAGE) 96
- TABLE 76 GLOBAL SAGE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 96
- DNA Chips 97
- TABLE 77 GLOBAL DNA CHIPS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 97
- Top Players 97
- TABLE 78 RECENT DEVELOPMENT 98
- BASED ON PROCESS 98
- TABLE 79 GLOBAL PROTEOMICS TECHNOLOGY BASED ON PROCESS MARKET BY PRODUCT,
THROUGH 2014 ($ MILLIONS) 98
- TABLE 80 GLOBAL PROTEOMICS TECHNOLOGY BASED ON PROCESS MARKET BY
GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 99
- PROTEIN, IDENTIFICATION, SEQUENCING, AND CHARACTERIZATION 99
- TABLE 81 GLOBAL PROTEIN, IDENTIFICATION, SEQUENCING, AND CHARACTERIZATION
MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 99
- TABLE 82 GLOBAL PROTEIN, IDENTIFICATION, SEQUENCING, AND CHARACTERIZATION
MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 100
- Top Players 100
- TABLE 83 RECENT DEVELOPMENT 100
- TABLE 83 (CONTINUED) 101
- TANDEM MASS SPETROMETRY (TD/MS) 101
- TABLE 84 GLOBAL TANDEM MS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 102
- CIRCULAR DICHROISM (CD) 102
- TABLE 85 GLOBAL CD MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS)
102
- SAMPLE PREPARATION 103
- TABLE 86 GLOBAL SAMPLE PREPARATION MARKET BY PRODUCT, THROUGH 2014 ($
THOUSANDS) 103
- TABLE 87 GLOBAL SAMPLE PREPARATION MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ THOUSANDS) 103
- Top Players 104
- Recent Developments 104
- April 23, 2009: New Product Launch 104
- CE SYSTEMS 104
- TABLE 88 GLOBAL CE SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 104
- PRESSURE CYCLING TECHNOLOGY 105
- TABLE 89 GLOBAL PRESSURE CYCLING TECHNOLOGY MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 105
Chapter-5: PROTEOMICS SERVICES MARKET 8
- TABLE 90 GLOBAL PROTEOMICS SERVICES MARKET BY PRODUCT, THROUGH 2014 ($
MILLIONS) 106
- TABLE 91 GLOBAL PROTEOMICS SERVICES MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ MILLIONS) 106
- ANALYTICAL LABORATORY SERVICES 107
- TABLE 92 GLOBAL ANALYTICAL LABORATORY SERVICES MARKET BY PRODUCT, THROUGH
2014 ($ MILLIONS) 107
- TABLE 93 GLOBAL ANALYTICAL LABORATORY SERVICES MARKET BY GEOGRAPHIC
REGION, THROUGH 2014 ($ MILLIONS) 107
- QUALITY CONTROL OF PROTEINS AND PROTEIN IDENTIFICATION 108
- PROTEIN SEPARATION SERVICES 108
- PROTEIN SEQUENCING SERVICE 109
- DATA ANALYSIS AND MAINTENANCE 109
- TABLE 94 GLOBAL DATA ANALYSIS AND MAINTENANCE MARKET BY PRODUCT, THROUGH
2014 ($ THOUSANDS) 110
- TABLE 95 GLOBAL DATA ANALYSIS AND MAINTENANCE MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 110
- TABLE 96 GLOBAL BIOINFORMATICS AND COMPUTATIONAL PROTEOMICS MARKET BY
GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 111
- Top Players 111
- TABLE 97 RECENT DEVELOPMENTS 111
- TABLE 97 (CONTINUED) 112
- DOCUMENT ANALYSIS AND DATA MINING SERVICES 112
- TABLE 98 GLOBAL DOCUMENT ANALYSIS AND DATA MINING SERVICES MARKET BY
GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 112
- Top Players 113
- Recent Developments 113
- April 7, 2009 Agreements and Collaborations 113
Chapter-6: PROTEOMICS DATABASE AND SOFTWARE MARKET 26
- TABLE 99 GLOBAL PROTEOMICS DATABASE AND SOFTWARE MARKET BY PRODUCT,
THROUGH 2014 ($ MILLIONS) 114
- TABLE 100 GLOBAL PROTEOMICS DATABASE AND SOFTWARE MARKET BY GEOGRAPHIC
REGION, THROUGH 2014 ($ MILLIONS) 115
- PROTEOMICS SOFTWARE 115
- OPPORTUNITIES 115
- Proteomics Software Vendors' Interest is Opening New Opportunities for
This Market 116
- Association with Academics Labs for Progression In Proteomics Software
Ensures Growth In Near Future 116
- Collaborations of Proteomics Software Providers with Institutes Open Up
New Opportunities 116
- TABLE 101 GLOBAL PROTEOMICS SOFTWARE MARKET BY PRODUCT, THROUGH 2014 ($
MILLIONS) 116
- TABLE 101 (CONTINUED) 117
- TABLE 102 GLOBAL PROTEOMICS SOFTWARE MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ MILLIONS) 117
- MARKET DRIVERS 117
- Proteomics Software Aids in Dynamic Analysis with Higher Throughput 117
- Identifying Low Abundance Proteins 118
- Detecting Post-Translational Modifications 118
- Use of Proteomics Software Leads to Better Quantitation of Proteomics Data
118
- Implementation and Integration of This Software Need the Attention of
Experienced Personnel, which Demands Time and Resources 118
- MS SOFTWARE 118
- TABLE 103 GLOBAL MS SOFTWARE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($
THOUSANDS) 119
- Top Players 119
- PROTEIN VALIDATION AND QUANTIFICATION TECHNOLOGIES 120
- TABLE 104 GLOBAL PROTEIN VALIDATION AND QUANTIFICATION TECHNOLOGIES MARKET
BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 121
- MICROARRAY SOFTWARE 121
- TABLE 105 GLOBAL MICROARRAY SOFTWARE MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ THOUSANDS) 121
- MF CHIP INSTRUMENT SOFTWARE 122
- TABLE 106 GLOBAL MF CHIP INSTRUMENT SOFTWARE MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 122
- PROTEIN STRUCTURAL ANALYSIS 122
- TABLE 107 GLOBAL PROTEIN STRUCTURAL ANALYSIS MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 123
- TANDEM MASS SPEC PROTEOMICS DATA VIEWER 123
- TABLE 108 GLOBAL TANDEM MASS SPEC PROTEOMICS DATA VIEWER MARKET BY
GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 123
- PRIMER ANALYSIS 124
- TABLE 109 GLOBAL PRIMER ANALYSIS MARKET BY GEOGRAPHIC REGION, THROUGH 2014
($ THOUSANDS) 124
- PROTEIN AND PEPTIDE IDENTIFICATION SOFTWARE 125
- TABLE 110 GLOBAL PROTEIN AND PEPTIDE IDENTIFICATION SOFTWARE MARKET BY
GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 125
- PROTEIN SEQUENCE AND PLASMID DRAWING ANALYSIS 126
- TABLE 111 GLOBAL PROTEIN SEQUENCE AND PLASMID DRAWING ANALYSIS MARKET BY
GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 127
- GEL IMAGE ANALYSIS SOFTWARE 127
- TABLE 112 GLOBAL GEL IMAGE ANALYSIS SOFTWARE MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 128
- PROTEOMICS DATABASES 128
- TABLE 113 GLOBAL PROTEOMICS DATABASES MARKET BY PRODUCT, THROUGH 2014 ($
MILLIONS) 128
- TABLE 114 GLOBAL PROTEOMICS DATABASES MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ MILLIONS) 129
- PROTEIN-PROTEIN INTERACTION 129
- TABLE 115 GLOBAL PROTEIN-PROTEIN INTERACTION MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 130
- Top Players 130
- TABLE 116 RECENT DEVELOPMENTS 130
- TABLE 116 (CONTINUED) 131
- PROTEIN SEQUENCE DATABASE 131
- TABLE 117 GLOBAL PROTEIN SEQUENCE DATABASE MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 132
- Top Players 132
- Recent Development 132
- April 3, 2009: New Technology Launch 132
- PROTEINS AND GENES 132
- TABLE 118 GLOBAL PROTEINS AND GENES MARKET BY GEOGRAPHIC REGION, THROUGH
2014 ($ THOUSANDS) 133
- GENE ONTOLOGY 133
- TABLE 119 GLOBAL GENE ONTOLOGY MARKET BY GEOGRAPHIC REGION, THROUGH 2014
($ THOUSANDS) 133
- 3-D STRUCTURES OF PROTEIN 134
- TABLE 120 GLOBAL 3-D STRUCTURES OF PROTEIN MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 134
- TABLE 121 RECENT DEVELOPMENT 134
- TABLE 121 (CONTINUED) 135
- GENERAL INFORMATION DATABASES 135
- TABLE 122 GLOBAL GENERAL INFORMATION DATABASE MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 135
- Top Players 136
- TABLE 123 RECENT DEVELOPMENTS 136
- GENERAL LABORATORY SOFTWARE PROGRAMS 136
- TABLE 124 GLOBAL GENERAL LABORATORY SOFTWARE PROGRAMS MARKET BY PRODUCT,
THROUGH 2014 ($ THOUSANDS) 136
- TABLE 125 GLOBAL GENERAL LABORATORY SOFTWARE PROGRAMS MARKET BY GEOGRAPHIC
REGION, THROUGH 2014 ($THOUSANDS) 137
- DESKTOP DATABASE, MANAGEMENT PROGRAMS, AND OPERATING SYSTEMS 137
- TABLE 126 GLOBAL DESKTOP DATABASE, MANAGEMENT PROGRAMS, AND OPERATING
SYSTEMS MARKET BY REGION, THROUGH 2014 ($ THOUSANDS) 137
- IMAGE PROCESSING AND ANALYSIS SOFTWARE PROGRAM 138
- TABLE 127 GLOBAL IMAGE PROCESSING AND ANALYSIS SOFTWARE PROGRAM MARKET BY
GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 138
- GRAPHING SOFTWARE PROGRAM 139
- TABLE 128 GLOBAL GRAPHING SOFTWARE PROGRAM MARKET BY GEOGRAPHIC REGION,
THROUGH 2014 ($ THOUSANDS) 139
Chapter-7: PROTEOMICS APPLICATIONS MARKET 14
- TABLE 129 GLOBAL PROTEOMICS APPLICATIONS MARKET THROUGH 2014 ($ MILLIONS)
140
- DRUG DISCOVERY 140
- TABLE 130 GLOBAL DRUG DISCOVERY APPLICATIONS MARKET BY PRODUCT, THROUGH
2014 ($ MILLIONS) 141
- MARKET DRIVERS 141
- Shortcomings of Gene-Based Drug Discovery Igniting Adoption of Proteomics
141
- Benefits Derived through Protein-Based Drug Design and Discovery Are
Expected to Be the Key Factor Contributing to Growth of Proteomics in the Drug
Discovery Market 141
- Need to Understand the Dynamics of Protein Element 142
- Continuous Search for Alternative and Efficient Methods to Deliver
Enhanced Drugs 142
- Increasing R&D Investments from Pharmaceutical and Biotech Companies 142
- Potential Market in Growing Economies 143
- Emerging Approaches and Innovations in Proteomics Improving Decision
Support Tools 143
- MARKET INHIBITORS 143
- Lack of Enhanced Computational Tools Limiting the Scope of Effective
Analysis 143
- Limited Drug Alternatives Restricting the Scope of Proteomics 144
- Prevailing Skepticism on the Feasibility of Manufacturing Protein-Based
Drugs on Larger Levels, Impairing the Adoption of Proteomics 144
- Limited Utility of Proteomics Due to Complexity Involved and Lack of
Adequately Trained Manpower 144
- DRUG DEVELOPMENT 144
- DRUG TARGET VALIDATION 145
- MARKET DRIVERS 145
- Advantages of Target-Based Drug Discovery Leading to Profuse Investment
from Drug Development Companies 145
- Application of Proteomics Enabling Process Efficiency 145
- Limited Knowledge on Protein Dynamics Limits High-Level Application 146
- ADME-TOX Profiling 146
- Target Identification 146
- DIAGNOSIS MARKET 147
- TABLE 131 GLOBAL DIAGNOSIS APPLICATIONS MARKET BY PRODUCT, THROUGH 2014 ($
MILLIONS) 147
- MARKET DRIVERS 147
- Better Analysis of Kidney Diseases by Proteomics Supports Its Growth in
Clinical Application 147
- Determination of Protein Expression for Normal and Diseased States Spurs
the Use of Proteomics as a Diagnostic Tool 148
- Continuous Advancements in the Proteomics Technologies 148
- MARKET INHIBITORS 148
- Complexity of Proteomes Acts as a Barrier for the Use of Proteomics in
Diagnostic Applications 148
- Inability of Proteomic Diagnostic Tools to Give Accurate and Reproducible
Results Slows Down Its Growth 148
- NEW BIOMARKER 148
- Market Drivers 149
- High-Quality Proteomics Equipment Have Effectively Helped in Biomarker
Detection in Complex Mixtures 149
- Biomarker Detection for Excessive Alcohol Consumption is becoming a
Popular Area for Proteomics 149
- Market Inhibitors 149
- Inability to Detect Some Important Biomarkers by Proteomics Tools
Restricts Its Adoption in New Biomarker Application 149
- A High Cost and Time Requirement for Biomarker Detection by Proteomics
Experiments Confines the Use of Proteomics 150
- PROTEIN-PROTEIN INTERACTION 150
- PROTEIN QUANTIFICATION 150
- PROTEIN PURIFICATION 150
- PROTEIN IDENTIFICATION 151
- GLOBAL THERAPY AND OTHERS MARKET 151
- TABLE 132 GLOBAL THERAPY AND OTHERS APPLICATIONS MARKET BY PRODUCT,
THROUGH 2014 ($ MILLIONS) 151
- THERAPY 152
- Market Drivers 152
- Proteomics Application in Anesthesiology is Evolving as a New Area in
Therapy 152
- Proteomics Is Gaining Popularity as a Cancer Diagnostic Tool 152
- Market Inhibitors 152
- Proteomics-Based Therapy Market Still Not an Established Segment 152
- Cost of Therapy Limiting the Scope 152
- FOOD AND NUTRITION 153
- HOMELAND SECURITY 153
Chapter-8: GEOGRAPHIC ANALYSIS OF PROTEOMICS MARKET 5
- 20/20 GENESYSTEMS, INC. 159
- TABLE 137 20/20 GENESYSTEMS, INC. PRODUCT PORTFOLIO 159
- STRATEGY 159
- ACTIVX BIOSCIENCES, INC. 160
- TABLE 138 ACTIVX BIOSCIENCES, INC. PRODUCT PORTFOLIO 160
- STRATEGY 160
- AGILENT TECHNOLOGIES 161
- TABLE 139 AGILENT TECHNOLOGIES PRODUCT PORTFOLIO 161
- STRATEGY 161
- TABLE 140 AGILENT TECHNOLOGIES STRATEGY 162
- AMGEN, INC. 162
- TABLE 141 AMGEN, INC. PRODUCT PORTFOLIO 162
- TABLE 141 (CONTINUED) 163
- STRATEGY 163
- ANASPEC, INC. 163
- TABLE 142 ANASPEC, INC. PRODUCT PORTFOLIO 164
- STRATEGY 165
- TABLE 143 ANASPEC, INC. STRATEGY 165
- APPLIED BIOSYSTEMS INC. 166
- TABLE 144 APPLIED BIOSYSTEMS INC. PRODUCT PORTFOLIO 166
- STRATEGY 167
- TABLE 145 APPLIED BIOSYSTEMS INC. STRATEGY 167
- ASTERAND, PLC 167
- TABLE 146 ASTERAND, PLC PRODUCT PORTFOLIO 168
- STRATEGY 168
- TABLE 147 ASTERAND, PLC STRATEGY 168
- BAYER TECHNOLOGY SERVICES 169
- TABLE 148 BAYER TECHNOLOGY SERVICES PRODUCT PORTFOLIO 169
- STRATEGY 169
- BECKMAN COULTER, INC. 170
- TABLE 149 BECKMAN COULTER, INC. PRODUCT PORTFOLIO 170
- STRATEGY 170
- BECTON, DICKINSON, AND COMPANY (BD) 171
- TABLE 150 BD PRODUCT PORTFOLIO 171
- STRATEGY 171
- BG MEDICINE 171
- TABLE 151 BG MEDICINE PRODUCT PORTFOLIO 172
- STRATEGY 172
- TABLE 152 BG MEDICINE STRATEGY 172
- BIACORE INTERNATIONAL AB 173
- TABLE 153 BIACORE INTERNATIONAL AB PRODUCT PORTFOLIO 173
- BIOCARTA, INC. 174
- TABLE 154 BIOCARTA, INC. PRODUCT PORTFOLIO 174
- BIO-RAD LABORATORIES, INC. 175
- TABLE 155 BIO-RAD LABORATORIES, INC. PRODUCT PORTFOLIO 175
- TABLE 155 (CONTINUED) 176
- STRATEGY 176
- TABLE 156 BIO-RAD LABORATORIES, INC. STRATEGY 176
- BRUKER BIOSCIENCES CORP. 177
- TABLE 157 BRUKER BIOSCIENCES CORPORATION PRODUCT PORTFOLIO 177
- STRATEGY 177
- CALIPER LIFE SCIENCES INC. 178
- TABLE 158 CALIPER LIFE SCIENCES INC. PRODUCT PORTFOLIO 178
- STRATEGY 178
- TABLE 159 CALIPER LIFE SCIENCES, INC. STRATEGY 179
- CAPRION PROTEOMICS, INC. 179
- TABLE 160 CAPRION PROTEOMICS, INC. PRODUCT PORTFOLIO 179
- STRATEGY 180
- CELLZOME AG 180
- TABLE 161 CELLZOME AG PRODUCT PORTFOLIO 180
- STRATEGY 180
- COMMONWEALTH BIOTECHNOLOGIES, INC. 181
- TABLE 162 COMMONWEALTH BIOTECHNOLOGIES, INC. PRODUCT PORTFOLIO 181
- STRATEGY 181
- DIGILAB BIOVISION GMBH 182
- TABLE 163 DIGILAB BIOVISION GMBH PRODUCT PORTFOLIO 182
- STRATEGY 182
- TABLE 164 DIGILAB BIOVISION GMBH STRATEGY 183
- DIONEX CORP. 183
- TABLE 165 DIONEX CORP. PRODUCT PORTFOLIO 183
- TABLE 165 (CONTINUED) 184
- STRATEGY 184
- TABLE 166 DIONEX CORP. STRATEGY 184
- DUALSYSTEMS BIOTECH AG 185
- TABLE 167 DUALSYSTEMS BIOTECH AG PRODUCT PORTFOLIO 185
- STRATEGY 186
- DYAX CORP. 186
- TABLE 168 DYAX CORP. PRODUCT PORTFOLIO 186
- STRATEGY 186
- EPROGEN 187
- TABLE 169 EPROGEN PRODUCT PORTFOLIO 187
- STRATEGY 187
- ERAGEN BIOSCIENCES 187
- TABLE 170 ERAGEN BIOSCIENCES PRODUCT PORTFOLIO 188
- STRATEGY 188
- EUROGENTEC 188
- TABLE 171 EUROGENTEC PRODUCT PORTFOLIO 189
- STRATEGY 189
- GE HEALTHCARE 190
- TABLE 172 GE HEALTHCARE PRODUCT PORTFOLIO 190
- TABLE 172 (CONTINUED) 191
- STRATEGY 191
- GENEART GMBH 192
- TABLE 173 GENEART GMBH PRODUCT PORTFOLIO 192
- STRATEGY 192
- GENEDATA AG 192
- TABLE 174 GENEDATA AG PRODUCT PORTFOLIO 193
- STRATEGY 193
- TABLE 175 GENEDATA AG STRATEGY 193
- GENENTECH, INC. 194
- TABLE 176 GENENTECH INC. PRODUCT PORTFOLIO 194
- STRATEGY 194
- TABLE 177 GENENTECH INC. STRATEGY 195
- INTRINSIC BIOPROBES, INC. 195
- TABLE 178 INTRINSIC BIOPROBES, INC. PRODUCT PORTFOLIO 195
- STRATEGY 196
- LIFESPAN BIOSCIENCES, INC. 196
- TABLE 179 LIFESPAN BIOSCIENCES, INC. PRODUCT PORTFOLIO 196
- STRATEGY 196
- MATRITECH, INC. 197
- TABLE 180 MATRITECH, INC. PRODUCT PORTFOLIO 197
- STRATEGY 197
- MATRIX SCIENCE, LTD. 197
- TABLE 181 MATRIX SCIENCE, LTD. PRODUCT PORTFOLIO 198
- STRATEGY 198
- MDS, INC. 198
- TABLE 182 MDS INC. PRODUCT PORTFOLIO 199
- STRATEGY 199
- MONARCH LIFESCIENCES 199
- TABLE 183 MONARCH LIFESCIENCES PRODUCT PORTFOLIO 199
- TABLE 183 (CONTINUED) 200
- STRATEGY 200
- NEXTGEN SCIENCES, LTD. 200
- TABLE 184 NEXTGEN SCIENCES, LTD. PRODUCT PORTFOLIO 201
- STRATEGY 201
- NONLINEAR DYNAMICS, LTD. 202
- TABLE 185 NONLINEAR DYNAMICS, LTD. PRODUCT PORTFOLIO 202
- STRATEGY 202
- TABLE 186 NONLINEAR DYNAMICS, LTD. STRATEGY 203
- THERMO SCIENTIFIC OWL SEPARATION SYSTEMS 203
- TABLE 187 THERMO SCIENTIFIC OWL SEPARATION SYSTEMS PRODUCT PORTFOLIO 203
- STRATEGY 204
- PERKINELMER, INC. 204
- TABLE 188 PERKINELMER, INC PRODUCT PORTFOLIO 204
- TABLE 188 (CONTINUED) 205
- STRATEGY 205
- TABLE 189 PERKINELMER, INC. STRATEGY 205
- PROLEXYS PHARMACEUTICALS, INC. 205
- TABLE 190 PROLEXYS PHARMACEUTICALS, INC. PRODUCT PORTFOLIO 206
- STRATEGY 206
- PROTAGEN AG 206
- TABLE 191 PROTAGEN AG PRODUCT PORTFOLIO 207
- STRATEGY 207
- PROTEA BIOSCIENCES, INC. 207
- TABLE 192 PROTEA BIOSCIENCES, INC. (USA) PRODUCT PORTFOLIO 207
- STRATEGY 208
- TABLE 193 PROTEA BIOSCIENCES, INC. (USA) STRATEGY 208
- TYRIAN DIAGNOSTICS 208
- TABLE 194 TYRIAN DIAGNOSTICS PRODUCT PORTFOLIO 208
- STRATEGY 209
- SHIMADZU BIOTECH 209
- TABLE 195 SHIMADZU BIOTECH PRODUCT PORTFOLIO 209
- TABLE 195 (CONTINUED) 210
- STRATEGY 210
- SOMALOGIC, INC. (USA) 210
- TABLE 196 SOMALOGIC, INC. (USA) PRODUCT PORTFOLIO 211
- STRATEGY 211
- SYNGENE 211
- TABLE 197 SYNGENE PRODUCT PORTFOLIO 212
- THERMO FISHER SCIENTIFIC, INC. 212
- TABLE 198 THERMO FISHER SCIENTIFIC INC. PRODUCT PORTFOLIO 213
- TABLE 198 (CONTINUED) 214
- STRATEGY 214
- VBC-GENOMICS BIOSCIENCE RESEARCH GMBH (AUSTRIA) 214
- TABLE 199 VBC-GENOMICS BIOSCIENCE RESEARCH GMBH (AUSTRIA) PRODUCT
PORTFOLIO 215
- STRATEGY 215
- XENCOR, INC. 215
- TABLE 200 XENCOR, INC. PRODUCT PORTFOLIO 215
Chapter-9: COMPANY PROFILES 57
Chapter-10: APPENDIX 15
- APPENDIX ONE 216
- PROTEOMIC TECHNOLOGY PATENTS FOR THE U.S., EUROPE AND JAPAN 216
- TABLE 201 PROTEOMIC TECHNOLOGY PATENTS FOR THE U.S., EUROPE AND JAPAN 216
- TABLE 201 (CONTINUED) 217
- TABLE 201 (CONTINUED) 218
- TABLE 201 (CONTINUED) 219
- TABLE 201 (CONTINUED) 220
- TABLE 201 (CONTINUED) 221
- TABLE 201 (CONTINUED) 222
- TABLE 201 (CONTINUED) 223
- TABLE 201 (CONTINUED) 224
- TABLE 201 (CONTINUED) 225
- TABLE 201 (CONTINUED) 226
- TABLE 201 (CONTINUED) 227
- APPENDIX TWO 228
- LIST OF ACRONYMS 228
- LIST OF ACRONYMS (CONTINUED) 229
- LIST OF ACRONYMS (CONTINUED) 230
|
